T cell dynamism and immune-related adverse events

被引：4

作者：

Johnson, Douglas B. ^{[1
]}

Balko, Justin M. ^{[1
]}

机构：

[1] Vanderbilt Univ, Dept Med, Med Ctr, Nashville, TN 37232 USA

来源：

CANCER CELL | 2023年 / 41卷 / 04期

关键词：

D O I：

10.1016/j.ccell.2023.02.006

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 ;

摘要：

Immune-related adverse events (irAEs) are a major complication of immune checkpoint inhibitors (ICIs) and occur in an unpredictable fashion. In a Med article, Nunez et al. profile peripheral blood markers in patients treated with ICIs, identifying that dynamic changes in proliferating T cells and cytokine upregulation are associated with irAEs.

引用

页码：658 / 659

页数：2

共 50 条

[21] Immune-related adverse events of immune checkpoint inhibitors: a review [J].

Yin, Qinan ;

Wu, Liuyun ;

Han, Lizhu ;

Zheng, Xingyue ;

Tong, Rongsheng ;

Li, Lian ;

Bai, Lan ;

Bian, Yuan .

FRONTIERS IN IMMUNOLOGY, 2023, 14

[22] Renal immune-related adverse events of immune checkpoint inhibitor [J].

Hu, Rongrong ;

Chen, Minjiang ;

Xu, Yan ;

Wang, Mengzhao ;

Zheng, Ke ;

Li, Xuemei .

ASIA-PACIFIC JOURNAL OF CLINICAL ONCOLOGY, 2020, 16 (06) :305-311

[23] In the Clinic Immune-Related Adverse Events of Immune Checkpoint Inhibitors [J].

Ramos-Casals, Manuel ;

Siso-Almirall, Antoni .

ANNALS OF INTERNAL MEDICINE, 2024, 177 (02) :ITC17-ITC32

[24] Immune-Related Adverse Events Associated with Immune Checkpoint Blockade [J].

Postow, Michael A. ;

Sidlow, Robert ;

Hellmann, Matthew D. .

NEW ENGLAND JOURNAL OF MEDICINE, 2018, 378 (02) :158-168

[25] Immune-Related Adverse Events Associated with Immune Checkpoint Inhibitors [J].

Daphne Day ;

Aaron R. Hansen .

BioDrugs, 2016, 30 :571-584

[26] Immune Checkpoint Inhibitors and Immune-Related Adverse Renal Events [J].

Herrmann, Sandra M. ;

Perazella, Mark A. .

KIDNEY INTERNATIONAL REPORTS, 2020, 5 (08) :1139-1148

[27] Immune-Related Adverse Events Associated with Immune Checkpoint Inhibitors [J].

Day, Daphne ;

Hansen, Aaron R. .

BIODRUGS, 2016, 30 (06) :571-584

[28] Prescreening of immune-related adverse events in our institute [J].

Sone, T. ;

Murai, T. ;

Itaya, K. ;

Koike, Y. ;

Ono, Y. ;

Nakamura, M. .

ANNALS OF ONCOLOGY, 2018, 29

[29] Nivolumab in melanoma: immune-related adverse events and efficacy [J].

Reactions Weekly, 2019, 1735 (1) :11-11

[30] Immune-related adverse events and the balancing act of immunotherapy [J].

Michael Conroy ;

Jarushka Naidoo .

Nature Communications, 13

← 1 2 3 4 5 →